Cargando…
Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma
BACKGROUND: The aim of the current study was to construct prognostic nomograms for individual risk prediction in elderly patients with osteosarcoma. METHODS: Data for 816 elderly patients (≥40 years old) with osteosarcoma between 2004 and 2016 from the Surveillance, Epidemiology, and End Results (SE...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449646/ https://www.ncbi.nlm.nih.gov/pubmed/34548809 http://dx.doi.org/10.2147/IJGM.S331623 |
_version_ | 1784569458918948864 |
---|---|
author | Liu, Xiaoqiang He, Shaoya Yao, Xi Hu, Tianyang |
author_facet | Liu, Xiaoqiang He, Shaoya Yao, Xi Hu, Tianyang |
author_sort | Liu, Xiaoqiang |
collection | PubMed |
description | BACKGROUND: The aim of the current study was to construct prognostic nomograms for individual risk prediction in elderly patients with osteosarcoma. METHODS: Data for 816 elderly patients (≥40 years old) with osteosarcoma between 2004 and 2016 from the Surveillance, Epidemiology, and End Results (SEER) database were randomly assigned to training (N=573) and internal validation (N=243) sets. The essential clinical predictors were identified based on least absolute shrinkage and selection operator (Lasso) Cox regression. Nomograms were constructed to predict the 1-, 3-, and 5-year cancer-specific survival (CSS) and overall survival (OS). RESULTS: Our LASSO regression analyses of the training set yielded five clinicopathological features (age, chemotherapy, surgery, AJCC stage, and summary stage) in the training cohort for the prognosis of elderly patients with osteosarcoma, while grade was only associated with OS and M stage was only associated with CSS. Construction of nomograms based on these predictors was performed to evaluate the prognosis of elderly patients with osteosarcoma. The C-index, calibration and decision curve analysis also showed the satisfactory performance of these nomograms for prognosis prediction. CONCLUSION: The constructed nomograms are helpful tools for exactly predicting the prognosis of elderly patients with osteosarcoma, which could enable patients to be more accurately managed in clinical practice. |
format | Online Article Text |
id | pubmed-8449646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-84496462021-09-20 Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma Liu, Xiaoqiang He, Shaoya Yao, Xi Hu, Tianyang Int J Gen Med Original Research BACKGROUND: The aim of the current study was to construct prognostic nomograms for individual risk prediction in elderly patients with osteosarcoma. METHODS: Data for 816 elderly patients (≥40 years old) with osteosarcoma between 2004 and 2016 from the Surveillance, Epidemiology, and End Results (SEER) database were randomly assigned to training (N=573) and internal validation (N=243) sets. The essential clinical predictors were identified based on least absolute shrinkage and selection operator (Lasso) Cox regression. Nomograms were constructed to predict the 1-, 3-, and 5-year cancer-specific survival (CSS) and overall survival (OS). RESULTS: Our LASSO regression analyses of the training set yielded five clinicopathological features (age, chemotherapy, surgery, AJCC stage, and summary stage) in the training cohort for the prognosis of elderly patients with osteosarcoma, while grade was only associated with OS and M stage was only associated with CSS. Construction of nomograms based on these predictors was performed to evaluate the prognosis of elderly patients with osteosarcoma. The C-index, calibration and decision curve analysis also showed the satisfactory performance of these nomograms for prognosis prediction. CONCLUSION: The constructed nomograms are helpful tools for exactly predicting the prognosis of elderly patients with osteosarcoma, which could enable patients to be more accurately managed in clinical practice. Dove 2021-09-14 /pmc/articles/PMC8449646/ /pubmed/34548809 http://dx.doi.org/10.2147/IJGM.S331623 Text en © 2021 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Liu, Xiaoqiang He, Shaoya Yao, Xi Hu, Tianyang Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma |
title | Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma |
title_full | Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma |
title_fullStr | Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma |
title_full_unstemmed | Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma |
title_short | Development and Validation of Prognostic Nomograms for Elderly Patients with Osteosarcoma |
title_sort | development and validation of prognostic nomograms for elderly patients with osteosarcoma |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449646/ https://www.ncbi.nlm.nih.gov/pubmed/34548809 http://dx.doi.org/10.2147/IJGM.S331623 |
work_keys_str_mv | AT liuxiaoqiang developmentandvalidationofprognosticnomogramsforelderlypatientswithosteosarcoma AT heshaoya developmentandvalidationofprognosticnomogramsforelderlypatientswithosteosarcoma AT yaoxi developmentandvalidationofprognosticnomogramsforelderlypatientswithosteosarcoma AT hutianyang developmentandvalidationofprognosticnomogramsforelderlypatientswithosteosarcoma |